Cargando…
Enabling Real-World Data to Accelerate the Development of Innovative Cancer Biomarkers
The molecular diagnostics industry has historically relied on sanitized clinical trials and commoditized data sources to inform its biomarker discovery and validation process—an under-substantiated approach that was ultra-expensive, resource-consuming and did not reflect how representative a new bio...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Georg Thieme Verlag KG
2023
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205392/ https://www.ncbi.nlm.nih.gov/pubmed/37228868 http://dx.doi.org/10.1055/s-0043-1768993 |